Previous investigations have suggested that the kallikrein-kinin system [KKS, the heteromeric dimer of HK and PK] of blood coagulation contributes to thrombogenicity of atherosclerotic plaque as well as angiogenesis in inflammation and cancer [27-29]. The gene discussed is KLK4; the disease is cancer.